On June 12, 2012, Xenetic Biosciences plc, Governor Deval Patrick and the Center announced that the UK-based, publicly-listed comopany plans to relocate its drug development operations to Massachusetts. The relocation decision follows the March 2011 visit to the UK by Governor Patrick and a delegation of state leaders from industry, academia and government.
June 12, 2012